Clinical Trials Logo
  1. Home
  2. Ventricular Arrhythmias
  3. NCT00273195

Clinical Investigation of the Medtronic EnTrust™ Implantable Cardioverter Defibrillator (ICD), Model D153ATG

Ventricular Arrhythmias Clinical Trial

Official title:
Clinical Investigation of the Medtronic EnTrust™ Implantable Cardioverter Defibrillator (ICD), Model D153ATG

Clinical Trial Summary

People who have a dangerously fast heart beat, or whose heart is at risk of stopping beating, may be in need of an electronic device called an implantable cardioverter defibrillator (ICD). An ICD is implanted surgically just under the skin in the upper chest area and it sends a strong electrical impulse, or shock, to the heart to return it to a normal rhythm.

The purpose of this study was to evaluate the safety and efficacy of the EnTrust ICD device. A feature of this device allows it to send small, painless electrical impulses (Anti-tachycardia pacing or ATP) to the heart instead of shocking it out of a rhythm that is too fast. Stopping a dangerous heart rhythm this way does not cause any pain whereas a shock to the heart can feel like a punch in the chest. This device also allows the heart to beat on its own when it can and helping it (by pacing, or sending it electrical signals) when it needs help. This feature is important because previously studies have shown that pacing the heart too often can increase the risk for heart failure or for atrial fibrillation (having too rapid of heart beats in the atrium).

This study is now complete and the device has since been approved by the FDA.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00273195
Study type Interventional
Source Medtronic Cardiac Rhythm Disease Management
Contact
Status Completed
Phase N/A
Start date April 2004
Completion date June 2005
View Details
See also
  Status Clinical Trial Phase
Completed NCT02275104 - Multimodal Image Processing Software to Guide Cardiac Ablation Therapy N/A
Completed NCT02699255 - Ventricular Arrhythmias After Pulmonary Vein Isolation
Not yet recruiting NCT06281977 - Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm Phase 3
Completed NCT02772380 - Acute Study to Collect Electrical Signals From the Heart Using a Special Lead N/A
Recruiting NCT01771172 - Acute Subcutaneous Defibrillation N/A
Enrolling by invitation NCT04394637 - Ultra High Resolution CT to Assess Role of Intramyocardial Fat and Delayed Enhancement in Ventricular Arrhythmogenesis
Completed NCT00146679 - Psychoeducational Intervention for ICD Patients (PEACE) N/A
Completed NCT04495712 - Antiarrhythmic Effects of Spironolactone in Patients With ICDs Phase 4
Active, not recruiting NCT01864031 - The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study N/A
Terminated NCT02227121 - Acute Defibrillation Study N/A
Active, not recruiting NCT01296022 - A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy N/A
Completed NCT00996086 - Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT)
Recruiting NCT01905007 - Study of Defibrillation Testing In Patients Undergoing Initial ICD Implantation Phase 4
Active, not recruiting NCT02864771 - Scandinavian Multicenter Study to Advance Risk Stratification in Heart Disease- Ventricular Arrhythmias
Recruiting NCT04921501 - Evaluation of Electrocardiographic Measurements by High Density Electrode ECG (ECG-HD) N/A
Completed NCT01594073 - Evaluation of Novel Biomarkers to Improve Risk Stratification and Patient Selection in Implantable Cardioverter-defibrillator (ICD) Therapy